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Abstract
The pathophysiologic mechanisms behind urologic disease are increasingly being elucidated. The object of this
investigation was to evaluate the publication policies of urologic journals during a period of progressively better
understanding and management of urologic disease. Based on the ISI Web of Knowledge Journal Citation Reports and the
PubMed database, the number and percentage of original experimental, original clinical, review or commentarial articles
published between 2002–2010 in six leading urologic journals were analyzed. ‘‘British Journal of Urology International’’,
‘‘European Urology’’, ‘‘Urologic Oncology-Seminars and Original Investigations’’ (‘‘Urologic Oncology’’), ‘‘Urology’’, ‘‘The
Journal of Urology’’, and ‘‘World Journal of Urology’’ were chosen, because these journals publish articles in all four
categories. The publication policies of the six journals were very heterogeneous during the time period from 2002 to 2010.
The percentage of original experimental and original clinical articles, related to all categories, remained the same in ‘‘British
Journal of Urology International’’, ‘‘Urologic Oncology’’, ‘‘Urology’’ and ‘‘The Journal of Urology’’. The percentage of
experimental reports in ‘‘World Journal of Urology’’ between 2002–2010 significantly increased from 10 to 20%. A distinct
elevation in the percentage of commentarial articles accompanied by a reduction of clinical articles became evident in
‘‘European Urology’’ which significantly correlated with a large increase in the journal’s impact factor. No clearly superior
policy could be identified with regard to a general increase in the impact factors from all the journals. The publication policy
of urologic journals does not expressly reflect the increase in scientific knowledge, which has occurred over the period
2002–2010. One way of increasing the exposure of urologists to research and expand the interface between experimental
and clinical research, would be to enlarge the percentage of experimental articles published. There is no indication that
such policy would be detrimental to a journal’s impact factor.
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Introduction
Experimental research in the field of urology has become
increasingly productive as scientists explore the molecular
background of urologic disease. Various scholarships provided
by the international urological society support not only under-
standing of urologic patho-physiology but also encourage trans-
lation of novel discoveries into new ideas for prevention, diagnosis
and treatment of urologic disorders. The pharmaceutical industry
concentrates on applied research, making university laboratories
dealing with in vitro and in vivo models attractive business
partners to conduct experimental research projects. A final reason
for the importance of experimental urologic research is that
expertise is a prerequisite to establishing national and international
collaboration.
Having established the importance of experimental research in
urology one might assume that urologic journals reflect the trend
and are publishing an increasing number of papers dealing with
experimental research. In fact, however, there are indications that
research is not reaching the majority of urologists. Only one-third
of the US academic medical centers exclusively conduct basic
science research [1]. Eberli and Atala have criticized that only a
minority of urologists are currently exposed to significant research
experience [2]. Olumi and Dewolf have asked for the support of
urology physicians with scientific expertise to drive the emergence
of clinically relevant therapies and to foster critical thinking about
feasible therapeutic possibilities [3]. Without doubt, increasing
urologists’ exposure to scientific research would be beneficial.
Communication between experimental and clinical urologic
scientists is of great importance [4] and urologic journals can serve
as a key platform where knowledge exchange takes place. This
investigation evaluates the publication policies of six leading
international urologic journals during the last 9 years.
Methods
Journals
Based on the subject category ‘‘Urology and Nephrology’’ in the
ISI Web of Knowledge Journal Citation Reports, six leading
urologic journals were selected: ‘‘British Journal of Urology
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nars and Original Investigations’’ (‘‘Urologic Oncology’’), ‘‘Urol-
ogy’’, ‘‘The Journal of Urology’’, and ‘‘World Journal of Urology’’.
The selected journals publish both original clinical as well as
original experimental articles in the field of urology and
additionally publish reviews and commentary articles. A quanti-
tative longitudinal study was conducted to examine the number of
published articles in each journal in the categories experimental,
clinical, review and commentary over a 9 year period (2002–
2010).
Analysis Strategy
Articles from each journal were categorized from 2002 to 2010
in 2 year intervals (2002, 2004, 2006, 2008, 2010) using the
PubMed database. Each journal was analyzed by year and
volume. Articles in supplementary magazines were excluded. The
following categories were defined:
Experimental: original experimental research articles
Clinical: original clinical research articles
Review: review articles
Commentarial: articles not fitting in the 3 previous groups:
comments, letters, editorials, errata, notices of retraction and
technical reports
The number of articles in each category was determined and
expressed as a percentage of the total number of articles in the
journal. Possible correlations between the percentage of a
particular article category and the journal’s impact factor were
examined.
To additionally explore whether the publication aims of the
journals have changed over the years, the written information for
authors as well as the aims and scopes of the journals between
2002 and 2010 were compared.
Statistics
Statistical analysis was performed with Pearson correlation and
regression coefficient and Neumann’s trend analysis. The trend
analysis was carried out from 2002 and from 2004. P values ,0.05
were considered significant. Evaluation was conducted using the
BiAS for windows statistical software program (Version 9.12).
Results
To evaluate whether urologic journals have changed their
publication policies during the past decade it was necessary to
select those magazines that cover a broad field of urology and
publish the four types of articles (original clinical, original
experimental, reviews, commentaries). From 73 journals listed in
the subject category ‘‘Urology and Nephrology’’ in the ISI Web of
Knowledge Journal Citation Reports only 6 journals fulfilled these
criteria. The overall number of articles appearing in all selected
journals increased approximately 30% over the years from 2002–
2010, except in ‘‘The Journal of Urology’’ where the number of
articles remained about the same. As the total number of articles in
all four categories increased over the period 2002 to 2010 (from
2,980 to 3,945), so did the number of original experimental articles
(from 283 to 370; +30.7%) as well as the number of original
clinical articles (from 1272 to 1493; +17.4%). Related to each
single journal, the number of original experimental articles in 2002
versus 2010 was as follows: 50 versus 63; +26% (‘‘British Journal of
Urology International’’), 23 versus 28; +22% (‘‘European Urolo-
gy’’), 158 versus 109; 231% (‘‘The Journal of Urology’’), 13 versus
24; +85% (‘‘Urologic Oncology’’), 32 versus 121; +278%
(‘‘Urology’’) and 7 versus 25; +257% (‘‘World Journal of
Urology’’). The percentage of articles in the experimental category
was about 10% of all the articles compiled from all the journals
(2002:11.52+/26.79%, 2004:8.74+/23.24%, 2006:7.71+/
23.63%, 2008:9.35+/25.63%, 2010:11.39+/25.44%).
Significant trends in the percentage of articles in some of the
four categories, experimental, clinical, review and commentary
were apparent in three journals: ‘‘World Journal of Urology’’,
‘‘European Urology’’ and ‘‘Urologic Oncology’’ (Figure 1). In
‘‘European Urology’’ clinical articles were reduced from approx-
imately 60% of all articles in 2002 to 20% in 2010. At the same
time commentarial articles increased from approximately 15% to
65%. In ‘‘World Journal of Urology’’ a significant trend was
apparent in the percentage of experimental papers, which
increased from about 10% in 2002 to 20% in 2010. From 2004
to 2010 trends were apparent in the journals ‘‘Urologic Oncology’’
and ‘‘World Journal of Urology’’, with respect to commentarial
and clinical articles. In ‘‘Urologic Oncology’’ commentarial
articles significantly decreased from approximately 70 to 50%.
In ‘‘World Journal of Urology’’, from 2004 to 2010, the
percentage of clinical articles significantly increased from about
30 to 50% and reviews decreased from about 60% to 20%.
Comparison of the journals’ aims and scopes between 2002 and
2010 revealed no differences with respect to ‘‘The Journal of
Urology’’, ‘‘Urology’’, ‘‘British Journal of Urology International’’,
‘‘Urologic Oncology’’ and ‘‘World Journal of Urology’’. Aims and
Scopes of ‘‘European Urology’’ were modified in as much as the
journal now publishes ‘‘peer-reviewed original articles on a wide
range of urological problems’’ (2010) instead of ‘‘scientific
contributions in the field of clinical and basic research in urology’’
(2002).
There was no significant correlation between the increase in the
number of articles over the time period 2002 to 2010 and the
impact factor, (Figure 2) which generally increased in all the
journals except ‘‘Urology’’, whose impact factor decreased slightly.
The lack of significance was due to a biphasic behavior in the
number of articles, increasing from 2002 to 2006 and maintaining
a plateau until 2010. During 2002 to 2010 the average impact
factor from all the journals increased steadily. In the journals with
significant changes in the distribution of categorical weight from
2002 to 2010, the impact factor increased in ‘‘European Urology’’
from 1.8 to 8.8, in ‘‘World Journal of Urology’’ from 1.7 to 2.4 and
in ‘‘Urologic Oncology’’ from 0.1 to 3.2. During the same time
period, in those journals with no significant changes in the
distribution of categorical weight, the impact factor in Journal of
Urology was 3.0 increasing to 3.8, in ‘‘British Journal of Urology
International’’ 1.6 increasing to 3.2 and in ‘‘Urology’’ 2.5
decreasing to 2.3 (Table 1).
Discussion
Management of urologic disease has undergone considerable
progress during the period from 2002 to 2010. During this time
period, in the four article categories - clinical, experimental, review
and commentary - in the six journals, approximately 10% was
devoted to experimental articles and 35% to clinical articles.
However, journal specific differences were apparent. One journal
significantly reduced the percentage of clinical articles (‘‘European
Urology’’), whereas another journal significantly increased both
the percentage of experimental and clinical articles (‘‘World
Journal of Urology’’).
Since authors preferably submit their work to journals with a
high impact factor, journals endeavor to adapt their editorial
policy to increase the impact factor. Labanaris et al. recently
provided evidence that journals publishing a high number of
reviews or which include considerable amounts of letters,
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their impact factors [5]. Since the journal volume is limited,
increasing the percentage of non-original articles must necessarily
diminish the printing space for original reports, which is
counterproductive to exposing urologists to original research.
‘‘European Urology’’ employed the publication strategy of
decreasing the percentage of clinical articles in favor of articles
with a commentarial content. The strategy was highly successful
with regard to the journal’s impact factor, which increased from
1.8 in 2002 to 8.8 in 2010. However, due to the policy some
Figure 1. Percent categorical changes in six urologic journals from 2002–2010. w=significant Neumann trend from 2002. #=significant
Neumann trend from 2004.
doi:10.1371/journal.pone.0052420.g001
Figure 2. Total number of articles (from all journals) and average impact factor (averaged from all journals) from 2002–2010.
doi:10.1371/journal.pone.0052420.g002
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mentarial material as a positive attribute in assessing an applicant’s
scientific reputation or evaluating scientific output, this strategy to
increase the impact factor may backfire and become obsolete.
‘‘Urologic Oncology’’ significantly decreased the percentage of
commentarial articles from 2004 to 2010. Nevertheless, its impact
factor was also enhanced from 0.1 in 2002 and 1.4 in 2004 to 3.2
(2010).
‘‘World Journal of Urology’’ adopted a diametrically opposed
strategy, increasing the percentage of original research articles.
Considering the publication policies from 2004 to 2010 it is
apparent that the increase in original research articles in ‘‘World
Journal of Urology’’ was due to an increase in both clinical and
experimental articles, at the cost of review articles. An increase in
the impact factor from 1.7 in 2002 to 2.4 in 2010 took place,
although this was much more modest, compared to ‘‘European
Urology’’ and ‘‘Urologic Oncology’’. In three journals, ‘‘The
Journal of Urology’’, ‘‘Urology’’, and ‘‘British Journal of Urology
International’’, no significant trends in categorical percentage,
indicating changes in their publication policies from 2002 to 2010
were apparent. Nevertheless, in these journals too, the impact
factor, for the most part, increased.
The publication policy of these six journals was very heteroge-
neous and no clearly superior policy could be identified with
regard to the general increase in impact from 2002 to 2010. The
increase in impact cannot solely be attributed to an enlarged
journal volume since the raise in the number of articles occurred
during the time period 2002–2006 and then reached a plateau,
while the average impact factor of all the journals continued to rise
steadily to 2010 (Figure 2). Therefore, extending journal volume
may be accompanied by an increase in impact, but a raise in the
impact factor can also occur without volume extension.
This study was restricted to journals from the ISI-category
‘‘Urology and Nephrology’’, excluding journals from other ISI-
categories, e.g. ‘‘Oncology’’ or ‘‘Pharmacology and Pharmacy’’,
which also publish articles with urology related content. Based on
this, we cannot generalize on whether the overall percentage of
original articles concerning urological disease printed in all
available journals has been expanded or not during the last years.
It cannot be ruled out that the publication policies of pharmaco-
logic and oncologic journals may differ from the publication
policies of the urologic journals analyzed here.
Considering the importance of original research in fostering
feasible therapeutic options and the various well-grounded appeals
for exposing urologists to more research, it does seem reasonable
to assume that there is room for expanding the percentage of
articles concerned with original research. Only 10% of the articles
in these six urologic journals were experimental and a doubling to
20%, as was apparent in ‘‘World Journal of Urology’’ was not
disadvantageous to the impact factor. Experimental research is the
basis for clinical research, which is preliminary to better disease
management. Expanding the interface between experimental
research and clinical research by increasing the percentage of
experimental articles published could contribute to increasing the
exposure of urologists to research, which presently is not optimal.
Possibly, establishing new urologic journals, which chiefly reflect
the molecular, biologic and pathophysiologic aspects of urological
disorders may be helpful in increasing the number of original
experimental publications. There is no indication that such policy
would be detrimental to a journal’s impact factor.
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Table 1. Correlation of impact factor (IF) 2002–2010 with percentage of articles in each category (clinical, experimental, review
and commentarial).
European Urology Journal of Urology
British Journal of Urology
International Urology
World Journal of
Urology Urologic Oncology
IF: 1.8–8.8 IF: 3.0–3.8 IF: 1.6–3.2 IF: 2.5–2.3 IF: 1.7–2.4 IF: 0.1–3.2
Clinical r=20.88 n.s. n.s. n.s. n.s. n.s.
p=0.05
Experimental n.s. r=20.89 n.s. n.s. n.s. n.s.
p=0.04
Review r=20.91 n.s. n.s. n.s. n.s. r=0.92
p=0.03 p=0.02
Commentarial r=0.89 n.s. n.s. n.s. n.s. n.s.
p=0.04
n.s.=not significant, r=regression, p indicates significance value.
doi:10.1371/journal.pone.0052420.t001
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